Amendment to Restricted Stock Grant Agreements between Nastech Pharmaceutical Company Inc. and Bruce R. York

Contract Categories: Business Finance › Modification Agreements
Summary

Nastech Pharmaceutical Company Inc. and Bruce R. York have agreed to amend several restricted stock grant agreements. The amendment states that if there is any conflict between these stock grant agreements and Mr. York's employment agreement dated March 7, 2008, the employment agreement will take precedence. This ensures that the terms of the employment agreement override any conflicting terms in the stock grant agreements. The amendment is effective as of March 7, 2008.

Read More Arrow
EX-10.2 3 exhibit2.htm EX-10.2 EX-10.2

NASTECH PHARMACEUTICAL COMPANY INC.

AMENDMENTS TO CERTAIN GRANT AGREEMENTS

WHEREAS, restricted stock grant agreements dated as of July 1, 2005, September 7, 2005, July 14, 2006 and July 2, 2007 (the “Agreements”) were entered into by and between Nastech Pharmaceutical Company Inc. (the “Company”), a Delaware corporation, and Bruce R. York (the “Grantee”); and

WHEREAS, the Company wishes to amend the Agreements and the Grantee wishes to do the same;

NOW, THEREFORE, the undersigned do hereby agree that the following sentence shall be added at the end of Section 1.3 of each of the Agreements:

Notwithstanding any provision of this Agreement to the contrary, if there is any conflict between the provisions of this Agreement and the employment agreement entered into by the Grantee and Nastech Pharmaceutical Company Inc. effective as of March 7, 2008 (the “Employment Agreement”), the provisions of the Employment Agreement shall control.

IN WITNESS WHEREOF, the parties have executed these Amendments effective as of March 7, 2008.

     
Company:
  NASTECH PHARMACEUTICAL COMPANY INC.
By: /s/ Steven C. Quay
 
    
 
   Name: Steven C. Quay, M.D., Ph.D.
Title: Chief Executive Officer
Grantee:
  /s/ Bruce R. York
 
    
 
   Name: Bruce R. York
Title: Chief Financial Officer